metreleptin — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-07-21 in 29d
ESTIMATED |
READOUT
Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Trea
Phase 3 · Partial Lipodystrophy |
Chiesi Farmaceutici S.p.A. | metreleptin |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|